Physician profile
Erin E Barth
NPI 1265951578
$9,742.72
in general payments reported to CMS, 2019-2025
35 companies · $3,207 in 2025
The $3,207 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,061 · 2022: $1,910 · 2023: $1,813 · 2024: $1,752 · 2025: $3,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,593 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,593.27 |
| Education | $178.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,357.91 | 2021-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $1,349.25 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Regeneron Healthcare Solutions, INC. | $771.80 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $633.20 | 2021-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $568.57 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Genzyme Corporation | $460.85 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $426.50 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $374.90 | 2021-2025 | Glassia, Cuvitru |
| Grifols USA, LLC | $358.17 | 2021-2025 | Prolastin-C Liquid, Xembify |
| United Therapeutics Corporation | $348.76 | 2021-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $286.80 | 2022-2025 | Zerbaxa, Winrevair, Capvaxive |
| Mallinckrodt Hospital Products INC. | $273.34 | 2021-2025 | Acthar |
| Verona Pharma, INC. | $270.47 | 2025 | Ohtuvayre |
| Insmed, INC. | $258.28 | 2021-2025 | Arikayce, Brinsupri |
| Amgen INC. | $232.86 | 2021-2025 | Tezspire |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $207.78 | 2025 | Yupelri |
| Baxter Healthcare | $190.65 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genentech USA, INC. | $187.18 | 2023-2025 | Xolair |
| Philips North America LLC | $151.76 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Electromed, INC. | $140.56 | 2021-2025 | Smartvest |
| Madrigal Pharmaceuticals | $139.79 | 2025 | Rezdiffra |
| Shionogi INC | $138.44 | 2022-2025 | Fetroja |
| Mayne Pharma Commercial LLC | $90.33 | 2021-2022 | |
| Abbvie INC. | $88.88 | 2025 | |
| Ani Pharmaceuticals, INC. | $83.90 | 2024 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $68.89 | 2022-2023 | |
| Inogen, INC. | $56.46 | 2022 | |
| Medtronic, INC. | $49.45 | 2024-2025 | Illumisite |
| Alexion Pharmaceuticals, INC. | $46.54 | 2022 | |
| Ucb, INC. | $37.36 | 2024 | Briviact |
| Paratek Pharmaceuticals, INC. | $28.04 | 2022-2023 | Nuzyra |
| Vifor Pharma, INC. | $17.82 | 2025 | Veltassa |
| Liquidia Technologies, INC. | $17.44 | 2025 | Yutrepia |
| Pulmonx Corporation | $14.94 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Janssen Pharmaceuticals, INC | $14.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Barth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.